Skip to main content
Log in

Parental Knowledge and Attitudes Toward Hypertrophic Cardiomyopathy Genetic Testing

  • Original Article
  • Published:
Pediatric Cardiology Aims and scope Submit manuscript

Abstract

Hypertrophic cardiomyopathy (HCM) is a common autosomal dominant condition with an increased risk of sudden cardiac death. Although clinical genetic testing can be used for confirmation of a clinical diagnosis as well as a predictive test, based on our clinical experience it is underutilized. Therefore, we developed and administered a questionnaire to assess potential determinants of parental interest in this testing. Of the 30 adult caregivers who participated, 80% had heard of genetic testing, whereas only 30% knew about genetic testing specifically for HCM. Once informed of the availability, 62% said they would consider testing in the future and 28% would consider it in the next year. Participants’ younger age, higher education level, knowledge of carrier testing, and positive view of genetic testing were significantly associated with the participant considering HCM genetic testing for their child (p ≤ 0.05). Based on a logistic regression model, age, education level, and knowing that HCM is an inherited disease were the best predictors of who would consider genetic testing. This study provides healthcare providers with a framework to understand caregivers’ knowledge and views of genetic testing, which can be used to improve clinical care for pediatric HCM patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Alcalai R, Seidman JG, Seidman CE (2008) Genetic basis of hypertrophic cardiomyopathy: from bench to the clinics. J Cardiovasc Electrophysiol 19:104–110

    PubMed  Google Scholar 

  2. Andersen J, Oyen N, Bjorvatn C, Gjengedal E (2008) Living with long QT syndrome: a qualitative study of coping with increased risk of sudden cardiac death. J Genet Couns 17:489–498

    Article  PubMed  Google Scholar 

  3. Brunger JW, Murray GS, O’Riordan M, Matthews AL, Smith RJ, Robin NH (2000) Parental attitudes toward genetic testing for pediatric deafness. Am J Hum Genet 67:1621–1625

    Article  CAS  PubMed  Google Scholar 

  4. Christiaans I, Birnie E, Bonsel GJ, Wilde AA, van Langen IM (2008) Uptake of genetic counseling and predictive DNA testing in hypertrophic cardiomyopathy. Eur J Hum Genet 16:1201–1207

    Article  PubMed  Google Scholar 

  5. Christiaans I, van Langen IM, Birnie E, Bonsel GJ, Wilde AA, Smets EM (2009) Genetic counseling and cardiac care in predictively tested hypertrophic cardiomyopathy mutation carriers: the patients’ perspective. Am J Med Genet 149A(7):1444–1451

    Google Scholar 

  6. Christiaans I, van Langen IM, Birnie E, Bonsel GJ, Wilde AA, Smets EM (2009) Quality of life and psychological distress in hypertrophic cardiomyopathy mutation carriers: a cross-sectional cohort study. Am J Med Genet 149A:602–612

    Article  PubMed  Google Scholar 

  7. Geisterfer-Lowrance AA, Kass S, Tanigawa G, Vosberg HP, McKenna W, Seidman CE et al (1990) A molecular basis for familial hypertrophic cardiomyopathy: a beta cardiac myosin heavy chain gene missense mutation. Cell 62:999–1006

    Article  CAS  PubMed  Google Scholar 

  8. Hershberger RE, Lindenfeld J, Mestroni L, Seidman CE, Taylor MR, Towbin JA (2009) Genetic evaluation of cardiomyopathy—a heart Failure Society of America Practice guideline. J Card Fail 15:83–97

    Article  PubMed  Google Scholar 

  9. Ho CY, Seidman CE (2006) A contemporary approach to hypertrophic cardiomyopathy. Circulation 113:e858–e862

    Article  PubMed  Google Scholar 

  10. Ingles J, Lind JM, Phongsavan P, Semsarian C (2008) Psychosocial impact of specialized cardiac genetic clinics for hypertrophic cardiomyopathy. Genet Med 10:117–120

    Article  PubMed  Google Scholar 

  11. Keren A, Syrris P, McKenna WJ (2008) Hypertrophic cardiomyopathy: the genetic determinants of clinical disease expression. Nat Clin Pract Cardiovasc Med 5:158–168

    Article  CAS  PubMed  Google Scholar 

  12. Lacour RA, Daniels MS, Westin SN, Meyer LA, Burke CC, Burns KA et al (2008) What women with ovarian cancer think and know about genetic testing. Gynecol Oncol 111:132–136

    Article  PubMed  Google Scholar 

  13. Marian AJ, Roberts R (2001) The molecular genetic basis for hypertrophic cardiomyopathy. J Mol Cell Cardiol 33:655–670

    Article  CAS  PubMed  Google Scholar 

  14. Maron BJ, Gardin JM, Flack JM, Gidding SS, Kurosaki TT, Bild DE (1995) Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary artery risk development in (young) adults. Circulation 92:785–789

    CAS  PubMed  Google Scholar 

  15. Maron BJ, McKenna WJ, Danielson GK, Kappenberger LJ, Kuhn HJ, Seidman CE et al (2003) American College of Cardiology/European Society of Cardiology Clinical Expert Consensus Document on Hypertrophic Cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines. J Am Coll Cardiol 42:1687–1713

    Article  PubMed  Google Scholar 

  16. McLaren CE, Barton JC, Adams PC, Harris EL, Acton RT, Press N et al (2003) Hemochromatosis and iron overload screening (HEIRS) study design for an evaluation of 100,000 primary care-based adults. Am J Med Sci 325:53–62

    Article  PubMed  Google Scholar 

  17. Meulenkamp TM, Tibben A, Mollema ED, van Langen IM, Wiegman A, de Wert GM et al (2008) Predictive genetic testing for cardiovascular diseases: impact on carrier children. Am J Med Genet 146A:3136–3146

    Article  PubMed  Google Scholar 

  18. Michie S, McDonald V, Bobrow M, McKeown C, Marteau T (1996) Parents’ responses to predictive genetic testing in their children: report of a single case study. J Med Genet 33:313–318

    Article  CAS  PubMed  Google Scholar 

  19. Patenaude AF, Basili L, Fairclough DL, Li FP (1996) Attitudes of 47 mothers of pediatric oncology patients toward genetic testing for cancer predisposition. J Clin Oncol 14:415–421

    CAS  PubMed  Google Scholar 

  20. Priori SG, Aliot E, Blomstrom-Lundqvist C, Bossaert L, Breithardt G, Brugada P et al (2001) Task force on sudden cardiac death of the European Society of Cardiology. Eur Heart J 22:1374–1450

    Article  CAS  PubMed  Google Scholar 

  21. Ryan MP, French J, al-Mahdawi S, Nihoyannopoulos P, Cleland JG, Oakley CM et al (1995) Genetic testing for familial hypertrophic cardiomyopathy in newborn infants. Br Med J (Clin Res Ed) 310:856–859

    CAS  Google Scholar 

  22. Segal ME, Polansky M, Sankar P (2007) Adults’ values and attitudes about genetic testing for obesity risk in children. Int J Pediatr Obes 2:11–21

    Article  PubMed  Google Scholar 

  23. Smets EM, Stam MM, Meulenkamp TM, van Langen IM, Wilde AA, Wiegman A et al (2008) Health-related quality of life of children with a positive carrier status for inherited cardiovascular diseases. Am J Med Genet 146A:700–707

    Article  PubMed  Google Scholar 

  24. Tanigawa G, Jarcho JA, Kass S, Solomon SD, Vosberg HP, Seidman JG et al (1990) A molecular basis for familial hypertrophic cardiomyopathy: an alpha/beta cardiac myosin heavy chain hybrid gene. Cell 62:991–998

    Article  CAS  PubMed  Google Scholar 

  25. van der Roest WP, Pennings JM, Bakker M, van den Berg MP, van Tintelen JP (2009) Family letters are an effective way to inform relatives about inherited cardiac disease. Am J Med Genet 149A:357–363

    Article  PubMed  Google Scholar 

  26. Van Driest SL, Ommen SR, Tajik AJ, Gersh BJ, Ackerman MJ (2005) Yield of genetic testing in hypertrophic cardiomyopathy. Mayo Clin Proc 80:739–744

    Article  PubMed  Google Scholar 

  27. van Langen IM, Birnie E, Leschot NJ, Bonsel GJ, Wilde AA (2003) Genetic knowledge and counseling skills of Dutch cardiologists: sufficient for the genomics era? Eur Heart J 24:560–566

    Article  PubMed  Google Scholar 

  28. van Langen IM, Birnie E, Schuurman E, Tan HL, Hofman N, Bonsel GJ et al (2005) Preferences of cardiologists and clinical geneticists for the future organization of genetic care in hypertrophic cardiomyopathy: a survey. Clin Genet 68:360–368

    Article  PubMed  Google Scholar 

  29. Laboratory for Molecular Medicine, Harvard Medical School and Partners Healthcare, Center for Genetics and Genomics Hypertrophic Cardiomyopathy Genetic Testing. Boston, MA. http://www.hpcgg.org/LMM/

  30. Zipes DP, Camm AJ, Borggrefe M, Buxton AE, Chaitman B, Fromer M et al (2006) ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death). J Am Coll Cardiol 48:e247–e346

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

The authors acknowledge Elizabeth Varga for her critical review of this manuscript. Funding for this project was received from The Research Institute at Nationwide Children’s Hospital.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Sara M. Fitzgerald-Butt.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Fitzgerald-Butt, S.M., Byrne, L., Gerhardt, C.A. et al. Parental Knowledge and Attitudes Toward Hypertrophic Cardiomyopathy Genetic Testing. Pediatr Cardiol 31, 195–202 (2010). https://doi.org/10.1007/s00246-009-9583-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00246-009-9583-2

Keywords

Navigation